ImmVira Announces Series C Financing with Leading Specialist Investors

SHENZHEN, China, Dec. 31, 2020 -- (Healthcare Sales & Marketing Network) -- ImmVira Group Company ("the Company"), a biotechnology platform dedicated to the development of oncolytic virus("OV") and vector type approaches to create more... Biopharmaceuticals, Oncology, Venture Capital ImmVira Group, oncolytic virus
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news